Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
may act as a brain-specific organic ion transporter [RGD, Feb 2006].. Additionally we are shipping SLC22A17 Proteins (4) and many more products for this protein.
Showing 10 out of 51 products:
Human Polyclonal SLC22A17 Primary Antibody for EIA, IF - ABIN500738
Devireddy, Gazin, Zhu, Green: A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. in Cell 2005
Show all 4 references for ABIN500738
Human Polyclonal SLC22A17 Primary Antibody for ELISA, WB - ABIN1003142
Koepsell, Endou: The SLC22 drug transporter family. in Pflügers Archiv : European journal of physiology 2004
Show all 4 references for ABIN1003142
Human Polyclonal SLC22A17 Primary Antibody for IHC, ELISA - ABIN1585236
Miyamoto, Asaka, Suzuki, Takatsu, Kashima, Shiozawa: Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma. in Experimental and molecular pathology 2011
Show all 2 references for ABIN1585236
Human Polyclonal SLC22A17 Primary Antibody for IF (p), IHC (p) - ABIN668691
Wu, Du, Lok, Lo, Xing: Lipocalin-2 enhances angiogenesis in rat brain endothelial cells via reactive oxygen species and iron-dependent mechanisms. in Journal of neurochemistry 2015
Cow (Bovine) Polyclonal SLC22A17 Primary Antibody for WB - ABIN2781648
Fang, Xu, Lu, Liao, Cai, Shen, Li: A novel alternative spliced variant of neutrophil gelatinase-associated lipocalin receptor in oesophageal carcinoma cells. in The Biochemical journal 2007
24p3R binds proteins filtered by the kidney with high affinity and may contribute to receptor-mediated endocy of proteins
cloning of the lipocalin (show APOD Antibodies) 24p3 receptor (24p3R). Ectopic 24p3R expression confers on cells the ability to undergo either iron uptake or apoptosis, dependent upon the iron content of the ligand.
Biochemical and Structural Characterization of the Interaction between the Siderocalin NGAL/LCN2 (Neutrophil Gelatinase-associated Lipocalin (show LCN2 Antibodies)/Lipocalin 2 (show LCN2 Antibodies)) and the N-terminal Domain of Its Endocytic Receptor SLC22A17.
Two novel variants in SLC22A17 and SLC22A7 (show SLC22A7 Antibodies) were significantly associated with anthracycline-induced cardiotoxicity.
Lipocalin 2 (show LCN2 Antibodies) might restore the health and regeneration potential of MSCs by decreasing senescence
No significant difference was found in the expressions of NGALR mRNA in placenta among moderate preeclampsia group, severe preeclampsia group and control group.
NGAL (show LCN2 Antibodies) and NGALR expression might be served as novel prognostic factors and potential therapeutic targets in Hepatocellular carcinoma.
This study suggested that NGAL (show LCN2 Antibodies) and NGALR expression are frequently up-regulated in gliomas, and are closely associated with poor clinical outcome.
These results suggested that SLC22A17, in cooperation with LCN2 (show LCN2 Antibodies), to be involved in the acquisition of aggressive behavior among endometrial carcinoma cells.
Neutrophil gelatinase-associated lipocalin receptor (NGALR) is differentially expressed in human glomerular disease and is significantly up-regulated by Il-1beta (show IL1B Antibodies) in HMC via MAPK/ERK (show MAPK1 Antibodies) activation.
NGALR hypomethylation contributes to its expression in esophageal carcinomas and that this overexpression may play a role in the pathogenesis of esophageal carcinomas.
may act as a brain-specific organic ion transporter
solute carrier family 22, member 17
, solute carrier family 22 (organic cation transporter), member 17
, 24p3 receptor
, brain-type organic cation transporter
, lipocalin-2 receptor
, organic cation transporter BOCT
, solute carrier family 22 member 17
, NGAL receptor
, neutrophil gelatinase-associated lipocalin receptor
, potent brain type organic ion transporter
, brain-specific organic ion transporter